CTX-10726 is a tetravalent PD-1 x VEGF-A bispecific antibody discovered and engineered at Compass. CTX-10726 is designed to synergistically deliver VEGF-A blockade and checkpoint inhibition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback